/Investor DB

Digitalis Ventures — 2021 Investments

5 investments dated 2021 · listed companies and verified rows first · show all

Alterome Therapeutics, Inc.alterome.cominDec 2021

Alterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic.

AI & Machine LearningBiotechDeep TechSan Diego, US

Eric A. Murphy(Executive Officer, Director, Promoter)inRyan B. Corcoran(Director, Promoter)Richard Heyman(Founder)

BoardThilo Schroeder(Director)inCarl Gordon(Director)inArjun Goyal(Director)in

Co-investorsCanaan PartnersNextech InvestOrbiMedVida VenturesNVIDIA

Code Oceancodeocean.comMay 2021

Code Ocean is a cloud computational research platform for reproducible code, data and environments in science.

New York, US

Simon Adar(Founder)in

BoardScott Tobin(Director)inJoshua Ruch(Director)inMarty Kahn(Director)

Co-investorsBattery VenturesBeaconsfield CapitalGaingelsKreos CapitalM12 (Microsoft's Venture Fund)Olima Ventures+2 more

Good Therapeuticsgoodtherapeutics.com𝕏Series A · Dec 2021 · $11Macquired by Roche

Portfolio company acquired by Roche.

BiotechSeattle, US

John Mulligan(Executive Officer, Director, Promoter)inMitchell Mutz(Director)Nicholas Walrod(Director)

BoardJohn McKearn(Director)inKarl Handelsman(Director)

Co-investorsRiverVest Venture Partners3x5 PartnersCodon CapitalRoche Venture Fund

Kingdomkingdomsuperculture.cominOct 2021

Kingdom Superculture develops functional health ingredients derived from natural microbes, targeting consumers seeking effective nutritional and health products.

BiotechConsumerFoodTechHealthtechNew MaterialsWellness & FitnessNew York City, US

Kendall Dabaghi(Founder)inRavi Sheth(Founder)inTom Blazejewski(Senior Machine Learning Scientist)Austin Kane(Bizops Associate)Peter Stein(Senior Data Engineer)

Co-investors4DX VenturesFour Acres CapitalPioneerShine CapitalSupernode VenturesValor Equity Partners+25 more

Rejuvenate Biorejuvenatebio.com𝕏Seed · Apr 2021 · $10M

Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.

BiotechHealthtechLongevitySan Diego, US

Noah Davidsohn(CSO, Co-Founder)inDaniel Oliver(CEO, Co-Founder)inGeorge Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)in

BoardDavid Zhu(Director)in

Co-investorsCompanion FundConnecticut InnovationsGaingelsKendall Capital PartnersLifespan Vision VenturesVCapital+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Aunt Bertha

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.